Comparison of FDA safety and efficacy data for KAMRA and Raindrop corneal inlays

Journal Title: International Journal of Ophthalmology - Year 2017, Vol 10, Issue 9

Abstract

"AIM: To provide a side-by-side analysis of the summary of safety and effectiveness data (SSED) submitted to the FDA for the KAMRA and Raindrop corneal inlays for the correction of presbyopia. METHODS: SSED reports submitted to the FDA for KAMRA and Raindrop were compared with respect to loss of corrected distance visual acuity (CDVA), adverse event rates, induction of astigmatism, retention of contrast sensitivity, stability of manifest refractive spherical equivalent (MRSE), and achieved monocular uncorrected near visual acuity (UNVA) at 24mo. RESULTS: Totally 442/508 of KAMRA patients and 344/373 Raindrop patients remained enrolled in the clinical trials at 24mo. The proportion of KAMRA and Raindrop patients who lost ≥2 lines of CDVA at 24mo was 3.4% and 1%, respectively. The adverse event rate was comparable between the devices. No significant inductions of astigmatism were noted. Both technologies induced a transient myopic shift in MRSE followed by a hyperopic shift and subsequent stabilization. Totally 87% of KAMRA and 98% of Raindrop patients attained a monocular UNVA of J5 (20/40) or better at 24mo, 28% of KAMRA and 67% of Raindrop patients attained a monocular UNVA of J1 (20/20) or better at 24mo. CONCLUSION: Both devices can be considered safe and effective, however, the results of corneal inlay implantation are mixed, and long-term patient satisfaction will likely depend on subjective expectations about the capabilities of the inlays. Variability in surgical technique and postoperative care within and between the two clinical trials diminishes the comparative power of this article."

Authors and Affiliations

Majid Moshirfar

Keywords

Related Articles

Suppression of corneal neovascularization by curcumin via inhibition of Wnt/β-catenin pathway activation

"AIM: To investigate whether curcumin suppressed corneal neovascularization (CNV) formation via inhibiting activation of Wnt/β-catenin pathway. METHODS: Suture-induced CNV was established on Sprague-Dawley (SD) rats. Cur...

Surgical treatment and visual outcomes of cataract with persistent hyperplastic primary vitreous

"AIM: To evaluate the surgical treatment and visual outcomes of eyes with cataract and persistent hyperplastic primary vitreous (PHPV). METHODS: This retrospective study included patients with cataract and PHPV treated w...

X-linked juvenile retinoschisis: phenotypic and genetic characterization

Juvenile X-linked retinoschisis (XLRS, MIM#312700) belongs to a group of the vitreoretinal dystrophies. We aimed to describe the phenotype-genotype correlation of three XLRS cases in juveniles with different novel mutati...

Placido disk-based topography versus high-resolution rotating Scheimpflug camera for corneal power measurements in keratoconic and post-LASIK eyes: reliability and agreement

"AIM: To compare the repeatability/reproducibility of measurement by high-resolution Placido disk-based topography with that of a high-resolution rotating Scheimpflug camera and assess the agreement between the two instr...

Interchangeability of corneal curvature and asphericity measurements provided by three different devices

"AIM: To evaluate the interchangeability of keratometric and asphericity measurements provided by three measurement systems based on different optical principles. METHODS: A total of 40 eyes of 40 patients with a mean ag...

Download PDF file
  • EP ID EP594620
  • DOI 10.18240/ijo.2017.09.18
  • Views 51
  • Downloads 0

How To Cite

Majid Moshirfar (2017). Comparison of FDA safety and efficacy data for KAMRA and Raindrop corneal inlays. International Journal of Ophthalmology, 10(9), -. https://europub.co.uk/articles/-A-594620